Screening Epitopes Through Comparative Analysis of Children and Mice Immune Responses to Pertussis Toxin Subunits

Salvatore Giovanni De-Simone1,2,3, Guilherme Curty Lechuga1, Paloma Napoleão-Pêgo1

  • 1Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.

Vaccines
|May 26, 2026
PubMed

Insights

This study reveals shared and unique antigenic targets of pertussis toxin (Ptx) in children and mice, offering insights for developing more effective pertussis vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbial Pathogenesis

Background:

  • Pertussis toxin (Ptx) is a key virulence factor and protective antigen of *Bordetella pertussis*.
  • Understanding Ptx's antigenic landscape is crucial for enhancing pertussis vaccine efficacy.
  • This study compares linear epitope profiles recognized by antibodies in vaccinated children and mice.

Purpose of the Study:

  • To compare linear epitope profiles of Ptx recognized by antibodies from vaccinated children and mice.
  • To identify conserved and species-specific immune targets across Ptx subunits (S1-S5).
  • To inform the design of improved pertussis vaccines.

Main Methods:

  • Synthesized overlapping peptide libraries covering the full-length Ptx sequence.
  • Analyzed sera from children and mice immunized with whole-cell pertussis vaccine.
  • Performed comparative and structural analyses of antibody-binding regions and epitope distribution.

Main Results:

  • Identified 12 major epitopes in mice and 24 in children, with 11 shared epitopes.
  • Observed species-specific epitopes in S1, S2, S3, S4, and S5 subunits.
  • Structural analysis showed non-uniform antibody recognition, highlighting S3 and S1 subunits, and identified 14 novel epitopes.

Conclusions:

  • Highlighted significant differences in murine and human immune responses to Ptx epitopes.
  • Demonstrated both conserved and species-specific antigenic targets of Ptx.
  • The identified epitopes provide a foundation for designing next-generation pertussis vaccines.
Abstract

Related Concept Videos